Literature DB >> 17201080

Prevention of cryoprecipitation during cardiopulmonary bypass in a patient with HIV-HCV co-infections.

Massimiliano Fontana1, Patrick Ruchat, Judith Horisberger, Vincent Aubert, Carole Mayor, François Spertini.   

Abstract

BACKGROUND: There are no guidelines for the management of patients with cryoglobulins during cardiopulmonary bypass (CPB) necessitating core hypothermia.
OBJECTIVE: To evaluate a simple, pragmatic protocol of in vitro temperature-dependent cryoprecipitation of serum in patients with cryoglobulinemia before elective cardiac surgery with CPB.
METHODS: A 44-year-old female patient was known for chronic hepatitis C and type III cryoglobulinemia. Elective surgery was planned for an aortic arch aneurysm. A differential serum cryoprecipitation profile was established in vitro prior to surgery.
RESULTS: Whereas, at temperatures < or = 15 degrees C, cryoglobulin levels were > or = 0.112 g/L (normal value < 0.05 g/L), at 20 degrees C and above, the precipitate was < or = 0.016 g/L. Accordingly, surgery was performed without any cryoglobulin-related complications at an extracorporeal circulation temperature of 22-24 degrees C, to minimise the risk of cryoprecipitation.
CONCLUSION: In elective cases of surgery with CPB and hypothermia, temperature-dependent differential serum cryoprecipitation profile may be an easy and efficient way to assess a safe peroperative level of temperature to avoid complications due to cryoglobulins, without enhancing the patient's tissue ischemia risks.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201080     DOI: 10.1177/0267659106073977

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  1 in total

1.  Coronary artery bypass grafting in a patient with active idiopathic cryoglobulinemia: revisiting the issue.

Authors:  Hafiz Abdul Moiz Fakih; Emmanuel Elueze; Rajiv Vij
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.